Apr 15, 2026 10:24AM
Nov 19, 2025 09:54AM
Nov 19, 2025 08:17AM
Nov 19, 2025 08:13AM
Nov 18, 2025 08:00AM
Oct 28, 2025 08:00AM
Aug 19, 2025 08:00AM ProPhase Labs Announces Filing of Definitive Proxy Statement and New Date for Special Meeting of Shareholders
Aug 13, 2025 06:59PM
Aug 13, 2025 08:00AM
Aug 11, 2025 08:00AM
May 20, 2025 04:24PM
May 20, 2025 08:00AM
May 13, 2025 08:00AM
Mar 31, 2025 08:00AM ProPhase Labs, Inc. Announces Financial Results for the Year Ended December 31, 2024
Mar 27, 2025 08:27AM
Dec 11, 2024 08:00AM
Nov 13, 2024 08:00AM
Nov 11, 2024 09:52AM
Oct 17, 2024 08:01AM
Oct 17, 2024 08:00AM
Aug 14, 2024 08:00AM ProPhase Labs Announces Financial Results for the Three Months Ended June 30, 2024
Aug 7, 2024 08:00AM
Jul 11, 2024 08:00AM
May 9, 2024 03:40PM
May 9, 2024 08:00AM
May 2, 2024 08:00AM
Mar 15, 2024 08:00AM
Mar 8, 2024 08:00AM PROPHASE LABS TO PRESENT 2023 YEAR END FINANCIAL RESULTS ON MARCH 15, 2024
Nov 9, 2023 08:00AM
Nov 2, 2023 08:00AM
Oct 17, 2023 08:00AM
Aug 10, 2023 10:40AM
Aug 10, 2023 09:24AM
Aug 10, 2023 08:00AM
Aug 2, 2023 08:00AM ProPhase Labs to Host Second Quarter 2023 Financial Results Conference Call on Thursday, August 10, 2023 at 11:00 a.m. Eastern Time
May 11, 2023 08:24AM
May 11, 2023 08:00AM
May 4, 2023 08:30AM
Mar 28, 2023 08:00AM
Mar 21, 2023 08:00AM
Dec 19, 2022 08:32AM
Dec 19, 2022 08:30AM ProPhase Labs Acquires Rights to Novel Esophageal Cancer Test
Nov 10, 2022 08:10AM
Nov 10, 2022 08:00AM
Nov 10, 2022 08:00AM
Nov 4, 2022 08:00AM
Nov 4, 2022 08:00AM
Aug 11, 2022 08:00AM
Aug 11, 2022 08:00AM ProPhase Labs Announces Record Second Quarter 2022 Financial Results
Aug 4, 2022 08:33PM

1,197,441 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All